Company intelligence / Profile preview

CellfBio

Malvern, Pennsylvania, United States

Ownership: Private
Development stage: Other

Overview

CellfBio is a biotechnology company focused on developing next-generation cell therapies using induced pluripotent stem cell (iPSC) technology. The company specializes in the efficient differentiation of iPSCs into high-purity endodermal lineage cells, including pancreatic beta cells and hepatocytes. By leveraging its proprietary platform, CellfBio aims to provide scalable and functional cell-based treatments for chronic conditions such as Type 1 diabetes and various liver diseases. The company's approach focuses on overcoming the limitations of primary cell sourcing and improving the consistency of therapeutic cell products.

Therapeutic areas: EndocrinologyCardiovascularGastroenterology
Modalities: Cell therapyInduced pluripotent stem cell derived therapy
Industry: Biotech

Beyond the preview

Go deeper on CellfBio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CellfBio.

Explore the full profile